STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 97 filers reported holding STOKE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 126 | 0.0% | 0.00% | – |
| Q2 2023 | $1 | 0.0% | 126 | 0.0% | 0.00% | – |
| Q1 2023 | $1 | 0.0% | 126 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | -100.0% | 126 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 126 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -33.3% | 126 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | 0.0% | 126 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | 0.0% | 126 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | +50.0% | 126 | +85.3% | 0.00% | – |
| Q2 2021 | $2,000 | -33.3% | 68 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | -25.0% | 68 | 0.0% | 0.00% | – |
| Q4 2020 | $4,000 | -33.3% | 68 | -63.2% | 0.00% | – |
| Q3 2020 | $6,000 | +50.0% | 185 | 0.0% | 0.00% | – |
| Q2 2020 | $4,000 | 0.0% | 185 | 0.0% | 0.00% | – |
| Q1 2020 | $4,000 | -20.0% | 185 | 0.0% | 0.00% | – |
| Q4 2019 | $5,000 | – | 185 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 17,161,713 | $666,561,000 | 74.20% |
| RTW INVESTMENTS, LP | 3,644,248 | $141,543,000 | 2.21% |
| Redmile Group, LLC | 2,544,062 | $98,811,000 | 1.39% |
| Cormorant Asset Management, LP | 1,437,807 | $55,844,000 | 1.24% |
| ACUTA CAPITAL PARTNERS, LLC | 45,000 | $1,748,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 150,729 | $5,854,000 | 0.45% |
| HighVista Strategies LLC | 13,692 | $532,000 | 0.40% |
| Birchview Capital, LP | 15,000 | $583,000 | 0.35% |
| Perceptive Advisors | 671,978 | $26,100,000 | 0.33% |
| GILDER GAGNON HOWE & CO LLC | 1,265,950 | $49,169,000 | 0.26% |